Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Keryx Biopharmaceuticals Inc (NASDAQ:KERX)

Delayed Data
As of Oct 05
 +0.03 / +0.94%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 10 analysts offering 12-month price forecasts for Keryx Biopharmaceuticals Inc have a median target of 11.50, with a high estimate of 19.00 and a low estimate of 1.50. The median estimate represents a +256.04% increase from the last price of 3.23.

Analyst Recommendations

The current consensus among 12 polled investment analysts is to Buy stock in Keryx Biopharmaceuticals Inc. This rating has held steady since October, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Nov 05

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 4.06%
Growthannually 17.29%


Growthquarterly 58.15%
Growthannually 37.68%
Key to the earnings and sales forecast charts.